Penumbra, Inc. Reports Second Quarter 2026 Financial Results
Go back to Penumbra, Inc. Reports Second Quarter 2026 Financial Results| Boston Scientific (NYSE: BSX) | Delayed: 51.83 +0.14 (0.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.69 | 52 Week High | $24.79 | |||
| Open | $52.83 | 52 Week Low | $15.67 | |||
| Day High | $52.99 | P/E | N/A | |||
| Day Low | $51.70 | EPS | $-0.09 | |||
| Volume | 16,296,421 | |||||
| (NYSE: PEN) | Delayed: 327.02 +0.27 (0.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $326.75 | 52 Week High | $79.49 | |||
| Open | $327.28 | 52 Week Low | $40.23 | |||
| Day High | $328.11 | P/E | N/A | |||
| Day Low | $326.72 | EPS | $0.00 | |||
| Volume | 251,611 | |||||
